Diffusion Pharmaceuticals Inc
Search For a Symbol
Diffusion Pharmaceuticals Inc Stock, NASDAQ:DFFN
300 East Main Street, Suite 201, Charlottesville, Virginia 22902-8759
United States of America
Number of Employees: 13
Diffusion Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in developing novel therapies that enhance the body's ability to deliver oxygen. The firm's product candidate, Trans Sodium Crocetinate, is being developed to enhance the diffusion of oxygen to tissues with low oxygen levels, also known as hypoxia. The company was founded by David G. Kalergis and John L. Gainer in 2001 and is headquartered in Charlottesville, VA.